It begins the selection of candidates to carry out a doctoral program in Regenerative Medicine between the SZBL and the IDIBELL. The program will run mainly at SZBL and will have a minimum six months stay at IDIBELL.
Begins the exchange program between IDIBELL and SZBL Read More »
The analysis show that these vaccines are safe and able to generate immunity in three out of four patients with immune system defects from birth, and in almost all patients treated with immunosuppressants who were evaluated in the study.
SARS-CoV-2 vaccines are safe and effective in people with immunodeficiency Read More »
Preliminary results show that the virus is active, reaches the primary tumor and metastases, and triggers the immune system response. In addition, at recommended doses, it has no important adverse effects.
Lack of family and social support and depressive symptoms are the main factors that impair patients’ ability to adopt healthy habits and practices.
The initiative, promoted by the Escolab program and carried out by IDIBELL, has been carried out with 4th year ESO students from the Escola Pia of Granollers.
An international consortium led by IRB Barcelona and the biotech company Merus, with the participation of IDIBELL and the Catalan Institute of Oncology, presents the preclinical data leading to the discovery of MCLA-158 and its action mechanism on cancer stem cells.
Two of the 2021 Biologist Day awards, celebrated by the College of Biologists of Catalonia, are given to two members of IDIBELL: Dr. Milagros González Garrigues and Dr. Núria Sala-Serra.
Two IDIBELL members receive 2021 Biologist Day awards Read More »
On Thursday afternoon, April 21, the Presentation Conference of the Bellvitge Campus Scientific and Technical Services for Clinical Research took place with the aim of raising awareness of the research support services that IDIBELL and UB offer to researchers in the Bellvitge Campus.
Researchers from IDIBELL, HUB, UAB and Hospital del Mar have identified the presence of an ALS biomarker outside the nucleus of skin cells of patients. The discovery can be very useful for cases in which diagnosis is difficult, or in those with a family history of ALS, and even for early diagnosis.
Study of skin biopsies offers potential as new diagnostic marker for ALS Read More »
IDIBELL, together with other scientific institutions in Catalonia, is already part of the Scientific Committee for Pessics de Ciència.
IDIBELL becomes a member of the Pessics de Ciència Scientific Committee Read More »
